FR2422402A1 - Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale - Google Patents

Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale

Info

Publication number
FR2422402A1
FR2422402A1 FR7909029A FR7909029A FR2422402A1 FR 2422402 A1 FR2422402 A1 FR 2422402A1 FR 7909029 A FR7909029 A FR 7909029A FR 7909029 A FR7909029 A FR 7909029A FR 2422402 A1 FR2422402 A1 FR 2422402A1
Authority
FR
France
Prior art keywords
methoxyethyl
nitrophenyl
dihydro
pyridine
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7909029A
Other languages
English (en)
Other versions
FR2422402B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6036687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2422402(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2422402A1 publication Critical patent/FR2422402A1/fr
Application granted granted Critical
Publication of FR2422402B1 publication Critical patent/FR2422402B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention a trait au domaine de la chimie médicale. Elle concerne un médicament contenant l'ester de 3- beta -méthoxyéthyle et de 5-isopropyle de la 1,4-dihydro-2,6-diméthyl-4-(3'-nitrophényl)pyridine. Application à la thépeutique cérébrale.
FR7909029A 1978-04-11 1979-04-10 Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale Granted FR2422402A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2815578A DE2815578C2 (de) 1978-04-11 1978-04-11 Neue pharmazeutische Verwendung von Nimodipin

Publications (2)

Publication Number Publication Date
FR2422402A1 true FR2422402A1 (fr) 1979-11-09
FR2422402B1 FR2422402B1 (fr) 1982-07-02

Family

ID=6036687

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7909029A Granted FR2422402A1 (fr) 1978-04-11 1979-04-10 Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale

Country Status (27)

Country Link
US (1) US4406906A (fr)
EP (1) EP0004650B1 (fr)
JP (3) JPS54135776A (fr)
AT (1) AT383271B (fr)
AU (1) AU532623B2 (fr)
BE (1) BE875457A (fr)
CA (1) CA1140853A (fr)
CH (3) CH649921A5 (fr)
DE (2) DE2815578C2 (fr)
DK (1) DK150479A (fr)
ES (1) ES479474A1 (fr)
FI (1) FI791162A (fr)
FR (1) FR2422402A1 (fr)
GB (1) GB2018134A (fr)
GR (1) GR71463B (fr)
HK (1) HK59188A (fr)
IE (1) IE51651B1 (fr)
IL (1) IL57030A (fr)
IT (1) IT1062201B (fr)
LU (2) LU88273I2 (fr)
NL (2) NL7902778A (fr)
NO (1) NO791009L (fr)
NZ (1) NZ190133A (fr)
PH (1) PH15574A (fr)
SE (1) SE447248B (fr)
SG (1) SG18688G (fr)
ZA (1) ZA791728B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
DE3142853A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung
JPS58172312A (ja) * 1982-04-02 1983-10-11 Toa Eiyou Kagaku Kogyo Kk ニフエジピン外用剤
JPS58177916A (ja) * 1982-04-13 1983-10-18 Kowa Co 外用剤
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
DE3316510A1 (de) * 1983-05-06 1984-11-08 Bayer Ag Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
EP0175671A1 (fr) * 1984-08-23 1986-03-26 Kuhlemann & Co. Préparation pharmaceutique et procédé pour l'administration de cette préparation pharmaceutique
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
US4758669A (en) * 1986-05-05 1988-07-19 Radiation Oncology Center Research And Development Corporation 4-(nitrone aryl) dihydropyridines
US5401759A (en) * 1989-11-16 1995-03-28 Miles Inc. Nimodipine enhanced growth and vascularization of neural grafts
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
JP2793410B2 (ja) * 1991-04-22 1998-09-03 インターナショナル・ビジネス・マシーンズ・コーポレイション ウェブ駆動装置及びテープ駆動装置
US5438144A (en) * 1991-07-30 1995-08-01 Troponwerke Gmbh & Co. Kg Use of 1,4-dihydropyridines in diabetes
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
DE4133257A1 (de) * 1991-10-08 1993-04-15 Bayer Ag N-methyl-nimodipin, verfahren zu seiner herstellung und seine verwendung als zerebraltherapeutikum
IT1255792B (it) * 1992-08-05 1995-11-16 Bayer Italia Spa Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
ATE146788T1 (de) * 1992-10-30 1997-01-15 Bayer Ag 4-heterocyclophenyl substituierte dihydropyridine
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
SE9203857D0 (sv) * 1992-12-22 1992-12-22 Astra Ab Use of an enantiomeric dihydropyridine
DK0657432T3 (da) 1993-12-10 2003-07-07 Bayer Ag Phenylsubstituerede 1,4-dihydropyridiner med cerebral aktivitet
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE4430094A1 (de) * 1994-08-25 1996-02-29 Bayer Ag Verwendung von 3,5-Dicarbonsäureester-1,4-Dihydropyridinen als Arzneimittel
US6078481A (en) * 1998-06-08 2000-06-20 Imation Corp. Tape storage cartridge having two-level tape path
AR027152A1 (es) * 2000-12-29 2003-03-12 Osmotica Argentina S A Composicion farmaceutica para el tratamiento de la enfermedad cerebrovascular cognitiva.
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
EP2316469A1 (fr) 2002-02-22 2011-05-04 Shire LLC Système de distribution et méthodes de protection et d'administration de dextroamphetamine
WO2007047406A2 (fr) * 2005-10-14 2007-04-26 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques liquides de nimodipine
US8748648B2 (en) * 2007-09-06 2014-06-10 Nektar Therapeutics Oligomer-calcium channel blocker conjugates
US9737478B2 (en) * 2009-09-28 2017-08-22 National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) Treatment of malaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
GB1455502A (en) * 1973-02-20 1976-11-10 Yamanouchi Pharma Co Ltd 1,4-dihydropyridine derivatives

Also Published As

Publication number Publication date
IT1062201B (it) 1983-07-29
FI791162A (fi) 1979-10-12
DE2815578A1 (de) 1979-10-18
IL57030A (en) 1982-09-30
SG18688G (en) 1989-07-07
IE51651B1 (en) 1987-02-04
AU4583579A (en) 1979-10-18
FR2422402B1 (fr) 1982-07-02
AU532623B2 (en) 1983-10-06
ES479474A1 (es) 1979-12-16
SE447248B (sv) 1986-11-03
ZA791728B (en) 1980-05-28
IT7921692A0 (it) 1979-04-09
NO791009L (no) 1979-10-12
CH649468A5 (de) 1985-05-31
JPS5730089B2 (fr) 1982-06-26
DE2967573D1 (en) 1986-03-13
LU88273I2 (fr) 1994-02-03
EP0004650B1 (fr) 1986-01-29
CH649921A5 (de) 1985-06-28
EP0004650A1 (fr) 1979-10-17
JPS54135776A (en) 1979-10-22
ATA262179A (de) 1986-11-15
DE2815578C2 (de) 1986-01-16
PH15574A (en) 1983-02-17
CH640734A5 (de) 1984-01-31
DK150479A (da) 1979-10-12
CA1140853A (fr) 1983-02-08
IE790756L (en) 1979-10-11
LU81133A1 (de) 1979-11-07
GR71463B (fr) 1983-05-30
JPS591412A (ja) 1984-01-06
NZ190133A (en) 1985-02-28
AT383271B (de) 1987-06-10
NL930034I2 (nl) 1993-10-01
JPS58219117A (ja) 1983-12-20
BE875457A (fr) 1979-10-10
NL930034I1 (nl) 1993-08-02
SE7903186L (sv) 1979-10-12
HK59188A (en) 1988-08-12
IL57030A0 (en) 1979-07-25
NL7902778A (nl) 1979-10-15
GB2018134A (en) 1979-10-17
US4406906A (en) 1983-09-27

Similar Documents

Publication Publication Date Title
FR2422402A1 (fr) Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale
BE864726A (fr) Compositions pharmaceutiques contenant de la cholestyramine
ES475379A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas ni- tro-sustituidas
ES485540A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados
KR910700040A (ko) 치아 미백제
FI822414L (fi) Syror av n-substituerade 2-pyrrolidon-4-karboxylsyror som befuktningsmedel
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
ES468525A1 (es) Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas
IT8620902A0 (it) Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria.
OA06797A (fr) Composé de platine, procédé de préparation et compositions pharmaceutiques en contenant.
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
DE3889302D1 (de) 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.
FR2600253B1 (fr) Nouvelles compositions pharmaceutiques a base de ketotifene
IT8521322A0 (it) Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche.
MC1878A1 (fr) Compositions pharmaceutiques
PT1150703E (pt) Terapia de esclerose multipla com chaperonina 10 e beta-interferao
KR850008664A (ko) 4-아미노-n-(1-페닐에틸)벤즈아미드의(s)-및(r)-에난티오머의 제조방법
FR2622103B1 (fr) Nouvelles compositions dermatologiques bronzantes insectifuges
ATA239688A (de) Zahnaerztliches spritzhandstueck
BR7601824A (pt) Liga dental e amalgama dental
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
DE68901491D1 (de) Verfahren, um die verfaerbung von emulsionen zu verhindern, und gegen verfaerbung resistente emulsionszusammensetzungen.
IT1095388B (it) Composizione farmaceutica per la somministrazione di pancreatina
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
DK116687D0 (da) Farmaceutisk praeparat indeholdende aenovantroneae

Legal Events

Date Code Title Description
ST Notification of lapse